Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Analyst Sees This ‘Specialty Pharma’ Stock Stuck Until Prescription Trends Improve

By Vandana Singh
August 8, 2:23 PM
Last week, Collegium Pharmaceutical Inc (NASDAQ:COLL) reported Q2 results—the first full quarter with BioDelivery—and beat revenue and EBITDA estimates.  HC Wainwright…

COLL

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications

By Vandana Singh
August 8, 2:09 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) will license a new group of adeno-associated viruses from the institute for undisclosed upfront payment and milestone…

SRPT

Read More
3 minute read
  • Entertainment
  • General
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories
  • Trading Ideas

Did Ryan Reynolds Cause A 10% Jump In This Streaming Company’s Stock?

By Chris Katje
August 8, 1:53 PM
A streaming company is seeing shares spike Monday and actor Ryan Reynolds might be the reason behind the move. Here are the details.

AAPL

Read More
1 minute read
  • General
  • News
  • Penny Stocks
  • Small Cap

Cenntro Forms New Subsidiary For Battery Production – Read What’s The Benefit

By Shivani Kumaresan
August 8, 1:27 PM
EV company Cenntro Electric Group Ltd (NASDAQ:CENN) has established a separate operating division and wholly-owned U.S. subsidiary, Cennatic Power Inc. (Cennatic). The new…

CENN

Read More
1 minute read
  • General
  • News
  • Politics

Russia, Ukraine Agree Not To Attack Against Merchant Vessels, Other Civilian Vessels, Port Facilties Engaged In Deal

By Benzinga Newsdesk
August 8, 12:59 PM
-Reuters

RSX

Read More
2 minute read
  • Entertainment
  • General
  • News

Sand Runs Out In Hourglass: ‘Days of Our Lives’ Moves After 50-Plus Years On Network TV To A Streaming Platform

By Chris Katje
August 5, 5:25 PM
Over the years, original shows and movies have shifted to streaming networks. Sports content is also making the move. Another television staple is headed to streaming with one of the longest-running soap operas headed to a streaming platform.

CMCSA

Read More
3 minute read
  • Entertainment
  • General
  • News
  • Top Stories
  • Trading Ideas

House of the ‘House of the Dragon’ Is On Fire: Why Is Warner Bros. Discovery Stock Tanking?

By Chris Katje
August 5, 4:56 PM
Since being spun off from AT&T Inc. (NYSE: T), media company Warner Bros. Discovery (NASDAQ: WBD) has seen shares fall. An earnings report and a new strategy shift are sending shares down further Friday.

DIS

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target

‘Street Underestimates Jazz Pharma’s Cash-Flow’ Says This Analyst

By Vandana Singh
August 5, 3:16 PM
HC Wainwright tweaked the price target on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to $204 with a reiterated Buy rating on slightly increased forward…

JAZZ

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

Biden Administration Expected To Sign New $1 Billion Ukraine Security Assistance Package In Coming Days; Package Includes Munitions And Armored Medical Transports

By Bill Haddad
August 5, 2:49 PM
-Reuters

RSX

Read More
1 minute read
  • General
  • Media
  • Trading Ideas

Disney Gets CNBC’s Fast Money Call Of The Day With These Final Trades

By AJ Fabino
August 5, 2:32 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

C

Posts pagination

Previous 1 … 2,254 2,255 2,256 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service